Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
2 | 03p2-6 | Germany | 2003 | HIV1 | B | Plasma | None |
Treatment History
Order | Regimen | Weeks |
1 | AZT | 26 |
2 | AZT+DDI | 9 |
3 | 3TC+AZT | 33 |
4 | 3TC+AZT+IDV | 11 |
5 | AZT+IDV | 13 |
6 | D4T+IDV | 8 |
7 | AZT+DDI+IDV | 31 |
8 | DDI+RTV+SQV | 31 |
9 | ABC+D4T+NFV | 2 |
10 | ABC+D4T+EFV+NFV | 48 |
11 | ABC+EFV+NFV | 22 |
12 | None | 26 |
13 | APV+DDI+LPV+NVP | 15 |
14 | APV+LPV+NVP | 9 |
15 | APV+LPV | 2 |
16 | 3TC+APV+AZT+LPV | 48 |
17 | 3TC+AZT+LPV | 10 |
18 | 3TC+IDV+LPV+TDF | 8 |
19 | 3TC+IDV+TDF | 28 |
20 | None | 4 |
21 | 3TC+ABC+AZT | 34 |
Protease Sequence
PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
I54V, V82A, L90M | L10F, L33F, F53L | I13V, K20T, R41K, K55R, R57K, I62V, L63P, A71I, I72V, I93L, C95F |
>03p2-6| codons 1-99 PQITLWQRPFVTVKIGGQLTEALLDTGADDTVFEEMNLPGKWKPKMIGGIGGLVRVKQYD QVPIEICGHKIVGTVLVGPTPANIIGRNLMTQLGFTLNF |
RT Sequence
NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
M41L, D67N, T69D, M184V, L210W, T215Y | A98AG | E28EK, T39A, E44D, V118I, K122E, I135T, S162C, Q207E, R211RK, L228H, V245E, L283I, I293V |
>03p2-6| codons 1-335 PISPIETVPVKLKPGMDGPKVKQWPLTKEKIKALVEICAELEKDGKISKIGPENPYNTPV FAIKKKNSDKWRKLVDFRELNKRTQDFWEVQLGIPHPGGLKKKKSVTVLDVGDAYFSIPL DEDFRKYTAFTIPSTNNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVI YQYVDDLYVGSDLEIGQHRTKIEELREHLWKWGFYTPDKKHQKEPPFHWMGYELHPDKWT VQPIELPEKDSWTVNDIQKLVGKLNWASQIYAGIKVKQLCKLIRGTKALTEVVPLTEEAE LELAENREILKEPVHGVYYDPSKDLIAEIQKQGQG |
References
Author | Title | Citation |
Rosen-Zvi, M | Selecting anti-HIV therapies based on a variety of genomic and clinical factors. | Bioinformatics, 2008 |